We are live on ! Find out more
XTNT icon

Xtant Medical Holdings
XTNT

22 hedge funds and large institutions have $45.2M invested in Xtant Medical Holdings in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more funds holding

Funds holding: 17 → 22 (+5)

0.08% more ownership

Funds ownership: 92.85% → 92.93% (+0.08%)

17% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 6

49% less capital invested

Capital invested by funds: $89.4M → $45.2M (-$44.2M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
22
Holders Change
+5
Holders Change %
+29.41%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
5
Increased
5
Reduced
6
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CGA
Crescent Grove Advisors
Illinois
+$153K
2
UBS Group
UBS Group
Switzerland
+$42.1K
3
Renaissance Technologies
Renaissance Technologies
New York
+$38.4K
4
VF
Virtu Financial
New York
+$31.5K
5
TSS
Two Sigma Securities
New York
+$21.6K

Top Sellers

Rank Fund Capital Flow
1
BCM
Bridgeway Capital Management
Texas
-$117K
2
TRCT
Tower Research Capital (TRC)
New York
-$20.2K
3
ACM
Altium Capital Management
New York
-$7.7K
4
HF
HRT Financial
New York
-$6.84K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$3.83K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$40.8M – – –
ACM
2
Altium Capital Management
New York
$3.5M -$7.7K -8,167 -0.1%
Renaissance Technologies
3
Renaissance Technologies
New York
$404K +$38.4K +40,800 +6%
BCM
4
Bridgeway Capital Management
Texas
$208K -$117K -123,900 -25%
CGA
5
Crescent Grove Advisors
Illinois
$91K +$153K +162,024 New
VF
6
Virtu Financial
New York
$33K +$31.5K +33,438 +136%
Vanguard Group
7
Vanguard Group
Pennsylvania
$25K -$3.83K -4,066 -8%
UBS Group
8
UBS Group
Switzerland
$25K +$42.1K +44,720 New
State Street
9
State Street
Massachusetts
$13K – – –
BlackRock
10
BlackRock
New York
$13K +$575 +610 +3%
TSS
11
Two Sigma Securities
New York
$13K +$21.6K +22,958 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$11K – – –
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
$8K +$13.1K +13,867 New
HF
14
HRT Financial
New York
$7K -$6.84K -7,257 -36%
Victory Capital Management
15
Victory Capital Management
Texas
$7K -$353 -375 -3%
TRCT
16
Tower Research Capital (TRC)
New York
$6K -$20.2K -21,393 -68%
OF
17
Outfitter Financial
Maine
$1K +$1.11K +1,177 New
Morgan Stanley
18
Morgan Stanley
New York
– +$1 +1 +3%
Bank of America
19
Bank of America
North Carolina
– +$24 +26 +55%

XTNT Hedge Fund Activity: Q4 2021 in Review

22 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q4 2021, worth a combined $45.2M — down 49% from $89.4M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new XTNT positions and 0 closed out — a net gain of 5 holders — while 5 added to existing stakes and 6 trimmed.

The largest buyer was Crescent Grove Advisors, opening a new position worth an estimated $153K. The largest seller was Bridgeway Capital Management, cutting an estimated $117K.

  • 22 institutional investors held Xtant Medical Holdings (XTNT) as of Q4 2021, up from 17 in Q3 2021.
  • Funds reported $45.2M of Xtant Medical Holdings stock for Q4 2021, down 49% quarter-over-quarter.
  • 5 funds opened new Xtant Medical Holdings positions in Q4 2021 and 0 closed out, a net change of +5 holders.
  • The largest Xtant Medical Holdings buyer in Q4 2021 was Crescent Grove Advisors, an estimated $153K added.
  • The largest Xtant Medical Holdings seller in Q4 2021 was Bridgeway Capital Management, an estimated $117K sold.

Based on aggregated 13F filings for Q4 2021.